知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Liu, Yan 天津医科大学被知名学者引用:117人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 詹启敏 中国 北京大学 中国工程院院士 MiR-205 inhibits the invasion and migration of esophageal squamous cell carcinoma by modulating SMAD..

2. 徐兵河 中国 中国医学科学院 2021中国工程院院士 Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a..

3. Evans, D. Gareth 英国 University of Manchester Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low..

4. Anthony,Howell 英国 University of Manchester Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low..

5. Robert,Clarke 美国 University of Minnesota The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiv..

6. Jos H,Beijnen 荷兰 Utrecht University Time above threshold plasma concentrations as pharmacokinetic parameter in the comparison of oral an..

7. Eitan,Friedman 以色列 Tel Aviv University Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers

8. Alison M,Dunning 英国 University of Cambridge Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer

9. Douglas F,Easton 英国 University of Cambridge Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer

10. Antonis C,Antoniou 英国 University of Cambridge Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer

11. Maria,Gazouli 希腊 University of ATHENS MicroRNAs as therapeutic targets in breast cancer metastasis

12. Mario,Campone 法国 University of Nantes A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patient..

13. Thomas,Bachelot 法国 Center LEON BERARD A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patient..

14. Veronique,Dieras 法国 Institute CURIE A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patient..

15. Fabrice,Andre 法国 Institute GUSTAVE ROUSSY A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patient..

16. Massimo,Dominici 意大利 University of Modena & Reggio Emilia Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Bre..

17. Gabriella,Sozzi 意大利 Foundation IRCCS Ist Nazl Tumori Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast ..

18. Tagliabue, Elda 意大利 Foundation IRCCS Ist Nazl Tumori Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast ..

19. Thompson, Paul M. 美国 University of Southern California Loco-regional recurrence after skin and nipple-sparing mastectomy and immediate breast reconstructio..

20. 王贵学 中国 重庆大学 教授 博导 "Plug and Play" Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3